Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_assertion type Assertion NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_head.
- NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_assertion description "[The number of drugs which suppress prolactin by acting on pituitary D2 receptors, and which are useful in the treatment of hyperprolactinemia, continues to increase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_provenance.
- NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_assertion evidence source_evidence_literature NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_provenance.
- NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_assertion SIO_000772 2126309 NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_provenance.
- NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_assertion wasDerivedFrom befree-2016 NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_provenance.
- NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_assertion wasGeneratedBy ECO_0000203 NP867412.RAMe7W3u8EfQV4PfcTmYRZK5lGnmb2F1-AHZQD_Eap6jo130_provenance.